gip/glp 1-agonist tirzepatide The Novel Dual GIP and GLP‐1 Receptor Agonist Attenuates Colon Cancer Development by Regulating Glucose Metabolism - Zhang - 2025 - Advanced Science GIPR/GLP-1R dual agonist therapies for

Description

Improvements in glycemic parameters and quality of life measures were also observed

Emphasize the importance of holistic lifestyleencouraging regular movement, quality sleep, stress management, reduced substance use, and strong social connectionsto support overall well-being and long-term success

284: 3037230382 [DOI] [PMC free article] [PubMed] [Google Scholar] 85.Farilla L, Hui H, Bertolotto C, et al

Youre not going to take the Lilly pill for its groundbreaking efficacy: Its convenience is the real pitch

The ongoing dedicated ophthalmic trial named as FOCUS study, which aims to evaluate semaglutides long-term effects on diabetic retinopathy, is now ongoing and could contribute to a comprehensive understanding of the true risk-benefit profile of these agents in patients with or at risk for diabetic retinopathy (NCT03811561) [104]